370 related articles for article (PubMed ID: 3001490)
1. Growth factors and oncogenes in human malignant glioma.
Westermark B; Nister M; Heldin CH
Neurol Clin; 1985 Nov; 3(4):785-99. PubMed ID: 3001490
[TBL] [Abstract][Full Text] [Related]
2. Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines.
Nistér M; Libermann TA; Betsholtz C; Pettersson M; Claesson-Welsh L; Heldin CH; Schlessinger J; Westermark B
Cancer Res; 1988 Jul; 48(14):3910-8. PubMed ID: 2454731
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor: roles in normal and v-sis transformed cells.
Deuel TF; Kimura A; Maehama S; Tong BD
Cancer Surv; 1985; 4(4):633-53. PubMed ID: 2824043
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor in human glioma.
Westermark B; Heldin CH; Nistér M
Glia; 1995 Nov; 15(3):257-63. PubMed ID: 8586462
[TBL] [Abstract][Full Text] [Related]
5. Clonal variation in the production of a platelet-derived growth factor-like protein and expression of corresponding receptors in a human malignant glioma.
Nistér M; Heldin CH; Westermark B
Cancer Res; 1986 Jan; 46(1):332-40. PubMed ID: 2998609
[TBL] [Abstract][Full Text] [Related]
6. A high-molecular-weight PDGF-like factor secreted by v-sis transformed cells leads to growth stimulation and transformation.
Klein R; Thiel HJ
Oncogene Res; 1988 May; 2(4):311-24. PubMed ID: 2840622
[TBL] [Abstract][Full Text] [Related]
7. Growth factors and cancer.
Goustin AS; Leof EB; Shipley GD; Moses HL
Cancer Res; 1986 Mar; 46(3):1015-29. PubMed ID: 3002607
[TBL] [Abstract][Full Text] [Related]
8. Signal transduction cascade shared by epidermal growth factor and platelet-derived growth factor is a major pathway for oncogenic transformation in NRK cells.
Masuda A; Kizaka-Kondoh S; Miwatani H; Terada Y; Nojima H; Okayama H
New Biol; 1992 May; 4(5):489-503. PubMed ID: 1515413
[TBL] [Abstract][Full Text] [Related]
9. [Microbiological approach to the treatment of brain tumors].
Kuratsu J; Ushio Y
Gan To Kagaku Ryoho; 1991 Feb; 18(2):195-200. PubMed ID: 1992913
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor in human malignancy.
Silver BJ
Biofactors; 1992 Apr; 3(4):217-27. PubMed ID: 1318717
[TBL] [Abstract][Full Text] [Related]
12. Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors.
Fleming TP; Saxena A; Clark WC; Robertson JT; Oldfield EH; Aaronson SA; Ali IU
Cancer Res; 1992 Aug; 52(16):4550-3. PubMed ID: 1322795
[TBL] [Abstract][Full Text] [Related]
13. Transformation-related growth factors and their receptors.
Bregman MD; Sipes NJ
Int J Cell Cloning; 1986 Jul; 4(4):224-36. PubMed ID: 3018097
[TBL] [Abstract][Full Text] [Related]
14. Growth factors, oncogenes and transformation. Part I: Growth factors and cell cycle control.
Paul D
Arzneimittelforschung; 1985; 35(4):772-9. PubMed ID: 2990498
[No Abstract] [Full Text] [Related]
15. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
Huang JS; Nishimura J; Huang SS; Deuel TF
J Cell Biochem; 1984; 26(4):205-20. PubMed ID: 6099364
[TBL] [Abstract][Full Text] [Related]
16. Growth factors and their receptors in development.
Adamson ED
Dev Genet; 1993; 14(3):159-64. PubMed ID: 8395365
[No Abstract] [Full Text] [Related]
17. Evidence for progressional changes in the human malignant glioma line U-343 MGa: analysis of karyotype and expression of genes encoding the subunit chains of platelet-derived growth factor.
Nistér M; Wedell B; Betsholtz C; Bywater M; Pettersson M; Westermark B; Mark J
Cancer Res; 1987 Sep; 47(18):4953-60. PubMed ID: 3497714
[TBL] [Abstract][Full Text] [Related]
18. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells.
Potapova O; Fakhrai H; Baird S; Mercola D
Cancer Res; 1996 Jan; 56(2):280-6. PubMed ID: 8542581
[TBL] [Abstract][Full Text] [Related]
19. Two independent amplification events on chromosome 7 in glioma: amplification of the epidermal growth factor receptor gene and amplification of the oncogene MET.
Wullich B; Sattler HP; Fischer U; Meese E
Anticancer Res; 1994; 14(2A):577-9. PubMed ID: 8017863
[TBL] [Abstract][Full Text] [Related]
20. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
